LPS and LAM activation of the U373 astrocytoma cell line: Differential requirement for CD14

Authors
Citation
Sl. Orr et P. Tobias, LPS and LAM activation of the U373 astrocytoma cell line: Differential requirement for CD14, J ENDOTOX R, 6(3), 2000, pp. 215-222
Citations number
36
Categorie Soggetti
Immunology
Journal title
JOURNAL OF ENDOTOXIN RESEARCH
ISSN journal
09680519 → ACNP
Volume
6
Issue
3
Year of publication
2000
Pages
215 - 222
Database
ISI
SICI code
0968-0519(2000)6:3<215:LALAOT>2.0.ZU;2-A
Abstract
CD14 is a membrane protein (mCD14) found on monocytes and neutrophils that is required for the innate immune response to lipopolysaccharide (LPS) and lipoarabinomannan (LAM). CD14 can also be found in serum as soluble CD14 (s CD14) that when bound to bacterial products, enables many non-CD14 bearing cells to be activated. Lipopolysaccharide binding protein (LBP) is a plasma protein that disaggregates and catalytically transfers LPS to CD14. To exa mine the role of CD14 and LBP in LAM-dependent activation, we used the U373 astrocyte cell line to stably express membrane-bound CD14 (U373-CD14). In serum-free conditions, U373-CD14 cells could respond to LAM stimulation as measured by expression of intracellular adhesion molecule-1 (ICAM-1), Vecto r control cells (U373-RSV) could not respond to LAM or LPS; but, upon the a ddition of serum as a source of soluble CD14, control U373-RSV cells could respond to LPS, but not LAM. Therefore, LAM can activate U373 cells only th rough membrane CD14 and not soluble CD14. We also demonstrate that this mem brane CD14-dependent LAM response is greatly facilitated by the addition of LBP.